Closing the Type 1 Diabetes gap in South-East Asia through government partnership working with non-government organisations.

Autor: Ng SM; University of Liverpool, Women and Children's Health, Liverpool, United Kingdom; Southport and Ormskirk NHS Trust, Southport, United Kingdom. Electronic address: may.ng@nhs.net., Malene IV; Kantha Bopha Children's Hospital, Phnom Penh, Cambodia., Nilar M; Mandalay Children's Hospital, Mandalay, Myanmar., Rassavong K; Mahosot Hospital, Vientiane, Lao People's Democratic Republic., Dung Vu C; Vietnam National Children's Hospital, Hanoi, Viet Nam., Hui Sieng Tan F; Sarawak General Hospital, Kuching, Malaysia., Yazid Jalaludin M; University Malaya, Kuala Lumpur, Malaysia., Toomey C; Action 4 Diabetes, Somerset, United Kingdom., Lek N; KK Women's and Children's Hospital, Singapore, Singapore.
Jazyk: angličtina
Zdroj: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2022 May; Vol. 187, pp. 109868. Date of Electronic Publication: 2022 Apr 05.
DOI: 10.1016/j.diabres.2022.109868
Abstrakt: This will be the first publication of Type 1 diabetes(T1D) outcomes in five low-middle-income countries (LMICs)-Laos, Malaysia, Vietnam, Cambodia and Myanmar in the Southeast Asia (SEA) region. The information obtained has been possible due to partnership programmes of non-government organisationAction4Diabetes (A4D) with defined local hospitalsthrough a Memorandum of Understandingsigned with the governments in SEAthat guarantees ongoing supplies of free insulin, blood glucose meter supplies, HbA1c tests and hospital emergency funds.
Participants: Between 2020 and 2021, 383 children and young people with T1D who were active in the A4D supported programmes were reviewed including information on health coverage, multidisciplinary team management, diabetic ketoacidosis (DKA) on admission and insulin regimen.
Results: Mean HbA1c between 2020 and 2021 for patients in these LMICs arereported for the first time. The average glycaemic index in the five SEAcountries reviewed between 2020 and 2021 were high at 83 mmol/mol (9.7%).
Conclusions: Government partnership working with non-government organisationsto support T1D from diagnosis to adulthood are the first steps to closing thegaps in many LMICs. Further epidemiological studies are needed to identify the glycaemic outcomes and DKA rates on admission for many of these countries.
(Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: